Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How has DISC1 enabled drug discovery?

Qi Wang1, Hanna Jaaro-Peled, Akira Sawa

  • 1Discovery Neuroscience, Wyeth Research, Princeton, NJ, USA.

Molecular and Cellular Neurosciences
|December 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An olfactory-prefrontal cortical circuit supports social recognition.

Research square·2026
Same author

Neurometabolites and Antipsychotic Response in Psychosis: A Mega-Analysis.

JAMA psychiatry·2026
Same author

Genetic interaction of <i>DISC1</i> and <i>Neuroligin</i> in regulation of glutamatergic synaptogenesis.

Frontiers in neuroscience·2026
Same author

Brain structural abnormalities in treatment-resistant schizophrenia.

Molecular psychiatry·2026
Same author

Soluble α2δ-1, altered in disease CSF, modulates network homeostasis and rescues deficits in a neuropsychiatric mouse model.

Neuron·2026
Same author

Cytomegalovirus-encoded immediate early 1 protein perturbs neural progenitor proliferation via interfering with host PML-DISC1 interaction.

The Journal of biological chemistry·2026
Same journal

Reflections from Mathias Bähr, PhD, Editor-in-Chief for Molecular and Cellular Neuroscience, 2017-2026.

Molecular and cellular neurosciences·2026
Same journal

Advancing molecular and cellular neuroscience: Vision and priorities from the new editor-in-chief.

Molecular and cellular neurosciences·2026
Same journal

Apolipoprotein E in Alzheimer's disease: A review of APOE receptors, signalling pathways and therapeutic opportunities.

Molecular and cellular neurosciences·2026
Same journal

Inadvertent p75NTR signaling might cause inconsistencies in the neuroprotection offered by mesenchymal stem cells.

Molecular and cellular neurosciences·2026
Same journal

Corrigendum to "Depressed mitochondrial function and electron transport Complex II-mediated H2O2 production in the cortex of type 1 diabetic rodents" [Mol. Cell. Neurosci. Volume 90, July 2018, Pages 49-59].

Molecular and cellular neurosciences·2026
Same journal

Sleep deprivation and hippocampal integrity: Oxidative stress mediated neuronal, memory and behavioral alterations and the restorative role of sleep recovery.

Molecular and cellular neurosciences·2026
See all related articles

Disrupted-in-schizophrenia 1 (DISC1) is a key gene linked to mental disorders. Its complex interactions offer new targets for psychiatric drug discovery and improved animal models for research.

Area of Science:

  • Neuroscience
  • Genetics
  • Psychiatry

Background:

  • Disrupted-in-schizophrenia 1 (DISC1) is a significant genetic risk factor for schizophrenia and other mental health conditions.
  • Understanding DISC1's role in neuronal development and signaling is advancing through identified binding partners and functional studies.

Purpose of the Study:

  • To review the current understanding of DISC1 biology and its implications for psychiatric drug discovery.
  • To explore the potential of the DISC1 interactome as a source of novel therapeutic targets.
  • To discuss the role of DISC1 in developing improved animal models for psychiatric disorders.

Main Methods:

  • Literature review of DISC1 binding partners and interaction networks.
  • Analysis of DISC1 expression patterns during development.

Related Experiment Videos

  • Evaluation of functional studies, including RNA interference and animal models.

    • Main Results:

    • The DISC1 interactome presents numerous potential therapeutic targets, including well-characterized and less-studied components.
    • DISC1 research has facilitated the development of new animal models relevant to psychiatric disorders.
    • DISC1 biology provides a framework for identifying novel drug targets and refining preclinical testing models.

    Conclusions:

    • DISC1 research is crucial for advancing psychiatric drug discovery by identifying new targets and improving disease models.
    • The DISC1 interactome offers a rich resource for developing innovative treatments for major mental disorders.
    • Further exploration of DISC1 biology is essential for translating genetic findings into effective therapeutic strategies.